Parnell Pharmaceuticals Holdings Ltd
OTC: PARNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Brad R. McCarthy CPA
- Headquarters
- Alexandria, Australia
- IPO year
- 2014
- Market cap
- $1.7M
- Website
- https://www.parnell.com
Loading PARNF…
Loading profile data…Frequently asked questions about PARNF
What does Parnell Pharmaceuticals Holdings Ltd (PARNF) do?
Parnell Pharmaceuticals Holdings Ltd is a well-established biopharmaceutical company that focuses on the entire lifecycle of animal health solutions, from development and manufacturing to global distribution. The company organizes its operations into four distinct business units: Companion Animal, Production Animal - U.S., Production Animal - Re...
Where does PARNF trade?
Parnell Pharmaceuticals Holdings Ltd (PARNF) trades on the Other OTC.
What sector is PARNF in?
Parnell Pharmaceuticals Holdings Ltd (PARNF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Parnell Pharmaceuticals Holdings Ltd?
Brad R. McCarthy CPA is the chief executive officer of Parnell Pharmaceuticals Holdings Ltd (PARNF).
Where is Parnell Pharmaceuticals Holdings Ltd headquartered?
Parnell Pharmaceuticals Holdings Ltd is headquartered in Australia.
Does PARNF pay a dividend?
Parnell Pharmaceuticals Holdings Ltd (PARNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PARNF go public?
Parnell Pharmaceuticals Holdings Ltd (PARNF) completed its initial public offering in 2014.